2009 January
Comparative Analysis of Mesenchymal
Stem Cells from Bone Marrow,
Umbilical Cord Blood, or
Adipose Tissue.
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy.
2014 January
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for theTreatment of Chronic DiscogenicLow Back Pain.
Human umbilical cord tissue-derived mesenchymal stem cells (HUC-MSCs) contain stem cells and possess the ability to regenerate degenerative discs.
2014 May
Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in
patients with type 2 diabetes mellitus.
Type 2 diabetes mellitus (T2DM) is a serious threat to human health and remains incurable.
2015 May
Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in
patients with type 2 diabetes.
Type 2 diabetes (T2D) is characterized by progressive and inexorable β-cell dysfunction, leading to insulin deficiency.
2015 June
Umbilical cord blood donation: public or private?
Umbilical cord blood (UCB) is a graft source for patients with malignant or genetic diseases who can be cured by allogeneic hematopoietic cell transplantation (HCT), but who do not have an appropriately HLA-matched family or volunteer unrelated adult donor.
2015 July
Transplantation of umbilical cord blood mononuclear cells increases levels of
nerve growth factor in the cerebrospinal
fluid of patients with autism.
We aimed to evaluate the levels of growth factors in the cerebrospinal fluid (CSF) of patients with autism after transplantation of umbilical cord blood mononuclear cells (CBMNCs).
2016 February
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey.
2017 February
Genetically re-engineered K562 cells significantly expand and functionally
activate cord blood natural killer cells: Potential for adoptive cellular
immunotherapy
Cord blood (CB) mononuclear cells were expanded with artificial antigen-presenting cells.
2017 April
Umbilical Cord Blood Transplantation: Challenges
and Future Directions.
An exciting new development is the use of either autologous or unrelated UCBT for nontraditional applications (outside of oncology) in neurology, endocrinology, and cardiology, for diseases that have significant worldwide impact.
2017 June
Anticancer cellular immunotherapies taken from umbilical cord blood.
The lack of highly effective drugs in many malignancies has prompted scientific interest in the development of alternative treatment strategies.
2017 October
Effect of Autologous Cord Blood Infusion
on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy:
A Randomized, Placebo‐Controlled Trial.
Cerebral palsy (CP) is a condition affecting young children that causes lifelong disabilities. Umbilical cord blood cells improve motor function in experimental systems via paracrine signaling.
2017 November
The first decade of advanced cell therapy clinical
trials using perinatal cells.
Advanced cell therapy with perinatal cells is a new field that covers a wide range of diagnoses but where most of the trials are early Phase.
2017 November
Cord Blood Banking for Potential Future Transplantation.
This policy statement is intended to provide information to guide pediatricians, obstetricians, and other medical specialists and health care providers in responding to parents’ questions about cord blood donation and banking as well as the types (public versus private) and quality of cord blood banks.
2018 September
Factors Influencing the rise of
Umbilical Blood Cell's Stem Cell Industry.
The lack of highly effective drugs in many malignancies has prompted scientific interest in the development of alternative treatment strategies.
2018 December
Umbilical Cord‐Derived Mesenchymal Stromal Cells (MSCs) for
Knee Osteoarthritis.
The lack of highly effective drugs in many malignancies has prompted scientific interest in the development of alternative treatment strategies.